Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus

Figure 6

The docked conformation of compound 5 with the receptor CDK5/p25 (PDB: 3O0G). Compound 5 is indicated by red color while the most active site of the CDK5 receptor is shown with purple color.